NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS – NOTE 11

11. INVESTMENT IN SUBSIDIARIES

  Group   Company  
  June
2016
R'000
  June
2015
R'000
  June
2016
R'000
  June 
2015 
R'000 
 
Unlisted investments at cost     428 144   –*  
* Amounts less than R1 000.

Name Main business Country of incorporation Interest held     
2016        
Directly held        
AfroCentric Resources (Pty) Ltd Dormant South Africa 100%      
AfroCentric Capital (Pty) Limited Dormant South Africa 100%      
ACT Healthcare Assets (Pty) Ltd Investment holding South Africa 71.3%**  
ACT Funding (Pty) Ltd Financing South Africa 100%      
Indirectly held        
AfroCentric Health (Pty) Limited Healthcare administration South Africa 71.3%      

The indirectly held subsidiary, Medscheme Holdings (Proprietary) Limited, operates in the healthcare administration and health risk management industry. The total aggregate assets, liabilities and results of Medscheme Holdings (Proprietary) Limited operations are summarised as follows:

Summarised statement of financial position of Medscheme Holdings (Proprietary) Limited:

  Group  
  June
2016
R'000
  June 
2015 
R'000 
 
Non-current assets (excluding intangible assets) 149 183    139 832    
Intangible assets  15 079    3 483    
Current assets  725 973    679 539    
Total assets  890 235    822 854    
Non-current liabilities  22 764    24 185    
Current liabilities  219 484    211 070    
Total liabilities  242 248    235 255    
Summarised statement of comprehensive income of Medscheme Holdings (Proprietary) Limited:             
Revenue  1 860 722    1 715 516    
Profit for the period  137 889    189 871    
Other comprehensive income  206    (114)   
Total comprehensive income  138 095    189 757    

Summarised statement of comprehensive income of Medscheme Holdings (Proprietary) Limited:

  Group  
  June 
2016 
R'000 
  June 
2015
R'000 
 
Net cash inflow from operating activities 66 108     228 051    
Net cash outflow from investing activities  (222 380)    (315 609)   
Net cash outflow from financing activities  36 468     6 553    
Net decrease in cash and cash equivalents  (119 804)    (81 005)  
* During the year, the Company’s shareholding in ACT Healthcare Assets (Pty) Ltd was diluted to 71.3% as a result of a share issue to Sanlam. The proceeds on disposal of R703 million were received in cash. An amount of R456.3 million (being the proportionate share of the carrying amount of the net assets of ACT Healthcare Assets (Pty) Ltd has been transferred to non-controlling interest (note 17). The difference of R246.6 million between the increase in the non-controlling interest and the consideration received has been credited directly to equity.

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS – NOTE 11